Hemos Bioscience and Geliya have established a strategic partnership, leveraging biotechnology to empower the beauty economy.

Category: Company News

Release time: 2025-12-17

Overview: On August 25, Hemos Bioscience and Geliya signed a strategic partnership in Chongqing to drive recombinant keratin industrialization in beauty and health through joint efforts in product development, technology transfer, and market application. Leveraging Geliya's nationwide network of 100+ stores and Hemos's core technology, the two parties integrate R&D-to-production chains to accelerate commercialization and build a two-way synergy of technology and channels. This cooperation marks a milestone in the deep integration of recombinant keratin technology with the beauty and health industry, and both will continue exploring innovations in cosmetic, scientific, and medical aesthetics.

 

On August 25, Hemos Bioscience and Geliya officially signed a strategic cooperation agreement in Chongqing. The two parties will focus on Product development, technology transfer, and market application The three core areas will jointly promote the industrialization and commercialization of recombinant keratin technology, accelerating the innovative application of high-end biomaterials in the beauty and health sectors.

 

 

As a well-known beauty chain brand integrating natural beauty, scientific beauty, and medical aesthetics, Geliya is dedicated to providing women with comprehensive beauty and health management services throughout their entire life cycle. The brand continuously introduces advanced technologies, products, and equipment from both domestic and international sources, coupled with high-quality, personalized services, thereby establishing a strong reputation within the industry. Currently, Geliya has more than 100 chain stores nationwide and boasts robust market channels and customer service capabilities.

 

This strategic partnership is based on the significant strengths of both parties in their respective fields. Through resource sharing and deep collaboration, it will fully unleash multi-dimensional synergies.

 

▶   Empowering Markets and Channels

Geliya leverages its store network and customer base to provide precise application scenarios and market access channels for the restructuring of keratin technology and products, accelerating market validation and promotion. Meanwhile, Hemos Bioscience empowers Gloria's service and product upgrades with its core technology, enhancing its market competitiveness.

 

▶ Accelerate the industrialization process.

Integrate the full-chain resources of both parties—including R&D, production, and application—to jointly promote the standardization and scaled production of recombinant keratin-related products, thereby shortening the time it takes for recombinant keratin technology to move from the laboratory to the market.

 

▶ Jointly build commercial barriers

By leveraging brand collaborations and complementary resources, we will enhance product competitiveness and drive innovation in our business model, achieving two-way value creation through the synergy of “technology + channels.” This strategic alliance of strong partners lays a solid foundation for both parties’ subsequent capitalization and IPO processes.

 

This strategic cooperation agreement not only represents an integration of resources between enterprises, but also marks a milestone in the deep integration of recombinant keratin technology with the beauty and health industry. Hemos Bioscience will further consolidate its leading position in the field of recombinant keratin, while Glorya will strengthen its service chain barriers through technological empowerment.

 

In the future, both parties will continue to explore innovative applications of recombinant keratin technology in fields such as bio-beauty, cosmetic science, and medical aesthetics. Hemos Bioscience, with technology at its core, provides customers with customized solutions, helping consumers access more efficient, safe, and high-quality services, and driving the beauty and health industry toward a higher-quality stage of development.

Keywords: Hemos Bioscience and Geliya have established a strategic partnership, leveraging biotechnology to empower the beauty economy.

Relevant Information

Company News

Industry News

Previous: New Cooperation, New Chapter | Hemos and Southwest University of Science and Technology Officially Inaugurate the “Industry-University-Research Practice Base”

Next: Milestone Collaboration! Hemos Bio × Leng Suan Ling: Launching a New Pathway for Anti-Sensitivity and Repair

%E7%AC%AC%E4%B8%80%EF%BC%8C%E6%9C%80%EF%BC%8C%E4%BC%98%E7%A7%80%EF%BC%8C%E5%A2%9E%E5%BC%BA%EF%BC%8C%E4%B8%80%E6%B5%81%EF%BC%8C%E5%8D%93%E8%B6%8A%EF%BC%8C%E9%A2%86%E5%85%88%EF%BC%8C%E5%85%88%E8%BF%9B%EF%BC%8C%E5%BC%95%E9%A2%86%EF%BC%8C%E6%96%B0%E5%8A%A8%E6%80%81%2F%2F%2F%E6%96%B0%E9%97%BB%E9%80%9F%E9%80%92%EF%BC%8C%E9%A2%86%E5%86%9B%E8%80%85%EF%BC%8C%E9%A6%96%EF%BC%8C%E9%A1%B6%E5%B0%96

Sorry，当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry，The current column has no content!

You can view other columns or return Home